(Q36539486)

14 August 2017

1 reference

title

Possible drug targets for celiac disease (English)

1 reference

14 August 2017

Carmen Gianfrani

1

1 reference

14 August 2017

Salvatore Auricchio

series ordinal

2

1 reference

14 August 2017

Riccardo Troncone

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

Expert Opinion on Therapeutic Targets

14 August 2017

published in

1 reference

14 August 2017

volume

10

1 reference

14 August 2017

issue

4

1 reference

14 August 2017

page(s)

601-611

1 reference

Molecular basis of celiac disease

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Refractory celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Identification of tissue transglutaminase as the autoantigen of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Adaptive and innate immune responses in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Structural basis for gluten intolerance in celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: implications for Celiac Sprue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Alterations of the intestinal transport and processing of gliadin peptides in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Future therapeutic options for celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

MHC ligands and peptide motifs: first listing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Specificity of tissue transglutaminase explains cereal toxicity in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Identification of transglutaminase-mediated deamidation sites in a recombinant alpha-gliadin by advanced mass-spectrometric methodologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Antigen analogs/MHC complexes as specific T cell receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

The state of the STATs: recent developments in the study of signal transduction to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Interleukin 15 is a potent stimulant of intraepithelial lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Anatomical basis of tolerance and immunity to intestinal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

IL-10-producing T regulatory type 1 cells and oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Agglutinating activity of gliadin-derived peptides from bread wheat: implications for coeliac disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Structural specificities and significance for coeliac disease of wheat gliadin peptides able to agglutinate or to prevent agglutination of K562(S) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Refractory coeliac disease: remission with infliximab and immunomodulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Interleukin 15 mediates epithelial changes in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.10.4.601

10.1517/14728222.10.4.601

21 January 2018

Identifiers

DOI

1 reference

14 August 2017

1 reference